Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis (HMS-02)

This study is currently recruiting participants.

Verified May 2010 by Central Hospital of Kanta-Hame

Sponsor:

Collaborators:

Linnan Klinikka, Hämeenlinna, Finland

Mehiläinen Hämeenlinna, Finland

Finnish Red Cross Blood Transfusion Service

Information provided by:

Central Hospital of Kanta-Hame

ClinicalTrials.gov Identifier:

NCT01119404

First received: May 6, 2010

Last updated: May 10, 2010

Last verified: May 2010

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2014
Estimated Primary Completion Date:	June 2014 (Final data collection date for primary outcome measure)

No publications provided by Central Hospital of Kanta-Hame

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Pohjantähti-Maaroos H, Palomäki A, Kankkunen P, Husgafvel S, Knuth T, Vesterinen K, Oksanen K. Arterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models. Ann Med. 2012 Aug;44(5):503-12. Epub 2011 Jul 4.

Pohjantähti-Maaroos H, Palomäki A, Hartikainen J. Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis. BMC Cardiovasc Disord. 2011 Jun 27;11:36.

To Top